AIM: This study aimed to assess whether group-based lifestyle counselling offered to a high-risk population subgroup had any effect beyond individual multifactorial interventions on fasting plasma glucose (FPG) and 2-h plasma glucose (2hPG) changes. METHODS: In a population-based study of 6784 participants, 4053 were determined to be at high risk based on a risk estimate of ischaemic heart disease or the presence of risk factors (smoking, hypertension, hypercholesterolaemia, obesity, impaired glucose tolerance). Of these subjects, 90% were randomized to high-intensity intervention (group A) and 10% to low-intensity intervention (group B). All participants went through health examinations, risk assessments and individual lifestyle counselling. Participants in group A were further offered group-based lifestyle counselling. The intervention was repeated after 1 and 3 years. A total of 2738 participants free of diabetes at baseline (1999-2001) and with at least one FPG and/or 2hPG measurement during 5 years of follow-up were included in the analyses. Differences in changes of plasma glucose between groups A and B were analyzed using multilevel linear regression. RESULTS: For FPG, crude 5-year changes were significantly different between the two groups (group A: -0.003 mmol/L vs group B: -0.079 mmol/L; P=0.0427). After adjusting for relevant confounders, no differences in FPG changes were observed (P=0.116). Also, no significant differences in the 5-year changes in 2hPG between the two groups were observed (group A: - 0.127 mmol/L vs group B: -0.201 mmol/L; P=0.546). CONCLUSION: Offering additional group-based intervention to a high-risk population subgroup had no clinical effects on changes in plasma glucose beyond those of individualized multifactorial interventions.
RCT Entities:
AIM: This study aimed to assess whether group-based lifestyle counselling offered to a high-risk population subgroup had any effect beyond individual multifactorial interventions on fasting plasma glucose (FPG) and 2-h plasma glucose (2hPG) changes. METHODS: In a population-based study of 6784 participants, 4053 were determined to be at high risk based on a risk estimate of ischaemic heart disease or the presence of risk factors (smoking, hypertension, hypercholesterolaemia, obesity, impaired glucose tolerance). Of these subjects, 90% were randomized to high-intensity intervention (group A) and 10% to low-intensity intervention (group B). All participants went through health examinations, risk assessments and individual lifestyle counselling. Participants in group A were further offered group-based lifestyle counselling. The intervention was repeated after 1 and 3 years. A total of 2738 participants free of diabetes at baseline (1999-2001) and with at least one FPG and/or 2hPG measurement during 5 years of follow-up were included in the analyses. Differences in changes of plasma glucose between groups A and B were analyzed using multilevel linear regression. RESULTS: For FPG, crude 5-year changes were significantly different between the two groups (group A: -0.003 mmol/L vs group B: -0.079 mmol/L; P=0.0427). After adjusting for relevant confounders, no differences in FPG changes were observed (P=0.116). Also, no significant differences in the 5-year changes in 2hPG between the two groups were observed (group A: - 0.127 mmol/L vs group B: -0.201 mmol/L; P=0.546). CONCLUSION: Offering additional group-based intervention to a high-risk population subgroup had no clinical effects on changes in plasma glucose beyond those of individualized multifactorial interventions.
Authors: Johanne M Justesen; Ehm A Andersson; Kristine H Allin; Camilla H Sandholt; Torben Jørgensen; Allan Linneberg; Marit E Jørgensen; Torben Hansen; Oluf Pedersen; Niels Grarup Journal: J Lipid Res Date: 2016-10-24 Impact factor: 5.922
Authors: Ehm A Andersson; Kristine H Allin; Camilla H Sandholt; Anders Borglykke; Cathrine J Lau; Rasmus Ribel-Madsen; Thomas Sparsø; Johanne M Justesen; Marie N Harder; Marit E Jørgensen; Torben Jørgensen; Torben Hansen; Oluf Pedersen Journal: Diabetes Date: 2013-07-08 Impact factor: 9.461
Authors: Aminu K Bello; Bilal Qarni; Arian Samimi; Julius Okel; Trish Chatterley; Ikechi G Okpechi; Ben Vandermeer; Branko Braam Journal: Kidney Int Rep Date: 2017-02-16
Authors: Maria Lukács Krogager; Regitze Kuhr Skals; Emil Vincent R Appel; Theresia M Schnurr; Line Engelbrechtsen; Christian Theil Have; Oluf Pedersen; Thomas Engstrøm; Dan M Roden; Gunnar Gislason; Henrik Enghusen Poulsen; Lars Køber; Steen Stender; Torben Hansen; Niels Grarup; Charlotte Andersson; Christian Torp-Pedersen; Peter E Weeke Journal: PLoS One Date: 2018-12-19 Impact factor: 3.240